Avecho Biotechnology Ltd has released a press release.
Investor Presentation
Filed with ASX ·
6ix hasn’t read this filing yet.
Avecho Biotechnology Limited on 6ix
In the deck
Story so far
Earlier from Avecho Biotechnology
- Prospectus
- Entitlement Offer to raise $11m for Phase 3 clinical trial
- Clinical CBD program expands with the Lambert Initiative
- December 2022 Quarterly Activities Report & Appendix 4C
- Athenex submits Avechos phytonadione to FDA pre-IND
Later from Avecho Biotechnology
- March 2023 Quarterly Activities Report & Appendix 4C
- Results of Entitlement Offer
- AVE commences manufacturing for Phase III trial
- Avecho licenses TPM for use in cancer drugs
- USPTO allows new TPM manufacturing patent
Follow Avecho Biotechnology into a list and get an email when it puts out news.
Follow Avecho Biotechnology